Alberto Bardelli
机构: University of Torino and IFOM ETS
每年引用次数
引用次数
引用: 76,178
H-指数: 113
I10-指数 : 275
出版物: 567
Different point mutations in the met oncogene elicit distinct biological properties.
S. GIORDANO , A. MAFFE , T. A. WILLIAMS , S. ARTIGIANI
The FASEB Journal 14 ( 2) 399 -406
89
2000
Protein tyrosine phosphatase PTP-S binds to the juxtamembrane region of the hepatocyte growth factor receptor Met.
Emma VILLA-MORUZZI , Franca PUNTONI , Alberto BARDELLI , Elisa VIGNA
Biochemical Journal 336 ( 1) 235 -239
31
1998
MULTI-DETERMINANTS ANALYSIS OF MOLECULAR ALTERATIONS FOR PREDICTING CLINICAL BENEFIT TO EGFR-TARGETED MONOCLONAL ANTIBODIES IN COLORECTAL CANCER
MF Frattini , AS Sartore-Bianchi , FD Di Nicolantonio , MN Nichelatti
ANNALS OF ONCOLOGY 21 I15 -I15
2010
High sensitive methods to identify K-RAS mutations increase the detection of non-responder metastatic colorectal cancer patients treated with anti-EGFR monoclonal antibodies
FM Molinari , LF Felicioni , MB Buscarino , SD De Dosso
ANNALS OF ONCOLOGY 21 I33 -I34
1
2010
The Full Oncogenic Activity of Ret/ptc2 Depends on Tyrosine 539, a Docking Site for Phospholipase Cy
CARLO BATTISTINI , ALBERTO BARDELLI , BARBARA PASINI , CLAUDIA PIUTTI
MOLECULAR AND CELLULAR BIOLOGY 2151 -2163
1996
Mutational profiling of kinases in glioblastoma
Bardelli A Bleeker FE , Lamba S , Zanon C , Molenaar RJ
BMC Cancer 14 718 -718
81
2014
Molecularly targeted therapies for colorectal cancer: Strategies for implementing translational research in clinical trials.
Heinz Zwierzina , Alberto Bardelli , Fortunato Ciardiello , Manuela Gariboldi
Current Opinion in Molecular Therapeutics 12 ( 6) 703 -711
1
2010
Identifying tumor origin using a gene expression-based classification map.
Ralph H. Hruban , Kornelia Polyak , Victor E. Velculescu , Alberto Bardelli
Cancer Research 63 ( 14) 4144 -4149
105
2003
Autophosphorylation promotes complex formation of recombinant hepatocyte growth factor receptor with cytoplasmic effectors containing SH2 domains.
Alberto Bardelli , Paolo Comoglio , I. Gout , Carola Ponzetto
Oncogene 7 ( 10) 1973 -1978
62
1992
K-ras and B-raf mutations and anti-EGFr antibody therapy
Alberto Bardelli , Salvatore Siena
26
2008
PRL-3 Expression in Metastatic Cancers
Bert Vogelstein , Bert Vogelstein , Kenneth W. Kinzler , Kathy E. Romans
Clinical Cancer Research 9 ( 15) 5607 -5615
285
2003
Knock-in of oncogenic mutations in human somatic cells as a tool to identify genoselective compounds
Giovanni Appendino , Margherita Gallicchio , Alberto Bardelli , Davide Zecchin
Molecular Cancer Therapeutics 3
2007
Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma
Carlo Zanon , Aldo Scarpa , Alberto Bardelli , Monica Rodolfo
Molecular Cancer Therapeutics 6
2007
Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor).
Luigi Naldini , Alberto Bardelli , Paola Longati , Paolo M. Comoglio
Oncogene 9 ( 1) 49 -57
182
1994
Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene.
L. Naldini , Luca Tamagnone , Alberto Bardelli , P. Longati
Cellular and Molecular Biology 40 ( 5) 597 -604
38
1994
Methods of treating patients having mutations in the extracellular domain of epidermal growth factor receptor (EGFR) with a combination of three fully human monoclonal anti-EGFR antibodies
Alberto Bardelli , Rachel C. Nering , Jeffrey David Kearns , Sabrina Arena
4
2016
Inactivation of dna repair as an anticancer therapy
Alberto Bardelli , Chris Torrance , Giovanni Germano
6
2017
Loss of the heme exporter FLVCR1a impairs mitochondrial functionality: a new approach against colorectal cancer
Emanuela Tolosano , Fiorella Altruda , Silvia Deaglio , Veronica Fiorito
European Iron Club Meeting 2018 42 -42
2018
The heme exporter FLVCR1A modulates cellular redox status and mitochondrial metabolism: implication in colorectal cancer
Emanuela Tolosano , Fiorella Altruda , Lorenzo Silengo , Veronica Fiorito
ISCAM 2017_4th Annual Meeting of the International Society of Cancer Metabolism 39 -39
2017
Costruzione di linee cellulari isogeniche per mutazioni associate al cancro e loro applicazione per approcci di farmacogenomica
Federica Di Nicolantonio , Alberto Bardelli , Sabrina Arena
2008